HomeInsightsStock Comparison

Mankind Pharma Ltd vs Panacea Biotec Ltd Stock Comparison

Mankind Pharma Ltd vs Panacea Biotec Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Mankind Pharma Ltd is ₹ 2381 as of 13 Jun 15:30.
  • The P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 48.1 on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Panacea Biotec Ltd changed from 0.8 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Market Cap of Mankind Pharma Ltd changed from ₹ 92029 crore on March 2024 to ₹ 92029 crore on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Panacea Biotec Ltd changed from ₹ 670.7 crore on March 2020 to ₹ 742.97 crore on March 2024 . This represents a CAGR of 2.07% over 5 years.
  • The revenue of Mankind Pharma Ltd for the Mar '25 is ₹ 3333 crore as compare to the Dec '24 revenue of ₹ 3285 crore. This represent the growth of 1.43% The revenue of Panacea Biotec Ltd for the Mar '25 is ₹ 168.83 crore as compare to the Dec '24 revenue of ₹ 169.88 crore. This represent the decline of -0.62%.
  • The ebitda of Mankind Pharma Ltd for the Mar '25 is ₹ 932.5 crore as compare to the Dec '24 ebitda of ₹ 903.08 crore. This represent the growth of 3.26% The ebitda of Panacea Biotec Ltd for the Mar '25 is ₹ 9.42 crore as compare to the Dec '24 ebitda of ₹ 14.35 crore. This represent the decline of -34.36%.
  • The net profit of Mankind Pharma Ltd changed from ₹ 494.19 crore to ₹ 424.65 crore over 8 quarters. This represents a CAGR of -7.30% The net profit of Panacea Biotec Ltd changed from ₹ 10.98 crore to ₹ -1.99 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Mankind Pharma Ltd changed from 31.56 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Panacea Biotec Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Mankind Pharma Ltd

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

About Panacea Biotec Ltd

  • India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines.
  • The Company has collaborations and tie-ups with leading national and international research organizations and corporations.
  • PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers.

Mankind Pharma Ltd News Hub

News

Mankind Pharma allots 57,709 equity shares under ESOP

Mankind Pharma has allotted 57,709 equity shares of face value of Re. 1/- each of the Comp...

Read more

10 Jun 2025 13:26

News

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs ...

Read more

23 May 2025 13:35

News

Mankind Pharma slides after Q4 PAT drops 11% YoY to Rs 421 cr

However, revenue from operations increased 27.19% year-on-year (YoY) to Rs 3,079.37 crore ...

Read more

22 May 2025 15:37

News

Board of Mankind Pharma approves incorporation of WoS in Sri Lanka

The Board of Mankind Pharma at its meeting held on 21 May 2025 has approved the incorporat...

Read more

21 May 2025 18:52

News

Mankind Pharma allots 92,512 equity shares under ESOP

Mankind Pharma has allotted 92,512 equity shares under ESOP on 21 May 2025. Consequent to ...

Read more

21 May 2025 14:16

News

Mankind Pharma to discuss results

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 21 May 2025...

Read more

09 May 2025 10:55

Panacea Biotec Ltd News Hub

News

Panacea Biotec announces inclusion of EmulsiPan into prestigious CEPI Adjuvant Library

Panacea Biotec announced the listing of EmulsiPan in the CEPI (Coalition for Epidemic Prep...

Read more

03 Jun 2025 12:08

News

Panacea Biotec declare Quarterly Result

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 30 May 2025...

Read more

26 May 2025 17:09

News

Panacea Biotec to announce Quarterly Result

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 February...

Read more

01 Feb 2025 10:27

News

Panacea Biotec Pharma launches 'NikoMom' brand of baby diapers and wipes

Panacea Biotec announced that the company's wholly owned subsidiary, Panacea Biotec Pharma...

Read more

03 Jan 2025 15:24

News

Panacea Biotec announces investment in Panacea Biotec Inc.

Panacea Biotec announced that the company's material subsidiary, Panacea Biotec Pharma (PB...

Read more

28 Dec 2024 14:00

News

Panacea Biotec hits the roof on bagging order worth Rs 127-cr from UNICEF

The company will supply 115 million doses of bivalent oral polio vaccine (bOPV) in Africa ...

Read more

26 Dec 2024 10:30

SWOT Analysis Of Mankind Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Panacea Biotec Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Mankind Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Panacea Biotec Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Mankind Pharma Ltd and Panacea Biotec Ltd

Which company has a larger market capitalization, Mankind Pharma Ltd or Panacea Biotec Ltd?

Market cap of Mankind Pharma Ltd is 98,296 Cr while Market cap of Panacea Biotec Ltd is 2,767 Cr

What are the key factors driving the stock performance of Mankind Pharma Ltd and Panacea Biotec Ltd?

The stock performance of Mankind Pharma Ltd and Panacea Biotec Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mankind Pharma Ltd and Panacea Biotec Ltd?

As of June 14, 2025, the Mankind Pharma Ltd stock price is INR ₹2381.95. On the other hand, Panacea Biotec Ltd stock price is INR ₹451.8.

How do dividend payouts of Mankind Pharma Ltd and Panacea Biotec Ltd compare?

To compare the dividend payouts of Mankind Pharma Ltd and Panacea Biotec Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions